IPRIPR2016-00408Final Written Decision
Boehringer Ingelheim GmbH et al.v.AbbVie Biotechnology Ltd.
IPR challenge of US 8889135.
Type
IPR
Filed
Dec 29, 2015
Instituted
Jul 7, 2016
Decided
—
Patent
Application
10163657
Inventor
Steven A. Fischkoff et al
Granted
Nov 18, 2014
01
Timeline
3 milestones
2015-12-29Petition filed
2016-07-07Institution
2017-07-06Terminated
02
Parties & counsel
Petitioner
Boehringer Ingelheim GmbH et al.
Counsel
Modi, Naveenet al
Patent Owner
AbbVie Biotechnology Ltd.
Counsel
O'Connor, Stevenet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →